55,823 results match your criteria Renal Cell Carcinoma


Management of Left Staghorn Calculus with Colorenal Fistula.

Urology 2021 May 12. Epub 2021 May 12.

Rutgers New Jersey Medical School, Division of Urology, Newark, NJ; RWJ BarnabasHealth, Saint Barnabas Medical Center, Division of Urology, Livingston, NJ.

Fistula formation between the kidney and the colon is a rare occurrence. Colorenal fistulas have been reported after renal cryoablation, calculous pyonephrosis, and renal cell carcinoma. Fistula formation is reported in as many as 35% of patients with Crohn's disease. Read More

View Article and Full-Text PDF

TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study.

Mod Pathol 2021 May 14. Epub 2021 May 14.

Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Eosinophilic, solid and cystic (ESC) renal cell carcinoma (RCC) is characterized by a solid and cystic architecture with cells showing abundant eosinophilic cytoplasm with hobnail arrangement and a cytokeratin 7-negative/cytokeratin 20-positive immunophenotype. Recent studies have suggested that bi-allelic events affecting TSC genes might play an important role for such tumors. However, only indirect evidence of the clonal origin of TSC mutation has been gathered so far. Read More

View Article and Full-Text PDF

Open transperitoneal partial nephrectomy in a horseshoe kidney.

BMJ Case Rep 2021 May 14;14(5). Epub 2021 May 14.

Geisinger Northeast Urology Department, Wilkes-Barre, Pennsylvania, USA.

We report the case of a 50-year-old Tibetan man who presented to an outpatient urology clinic after abdominal ultrasound for poorly defined abdominal pain demonstrated horseshoe kidney (HK) with a right moiety ~3.7 cm mass further characterised using contrast-enhanced CT scan (CECT). This dedicated imaging confirmed HK with a heterogeneously enhancing right upper pole 3. Read More

View Article and Full-Text PDF

Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer.

Cancer Treat Rev 2021 Mar 2;97:102172. Epub 2021 Mar 2.

Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.

Treatment outcomes have improved with the advent of immune checkpoint inhibitors and small molecule inhibitors. However, many patients do not respond with single agents. Consequently, ongoing research is focused on the use of combination therapies to increase clinical efficacy by potential synergistic effects. Read More

View Article and Full-Text PDF

Diffusion kurtosis imaging features of renal cell carcinoma: a preliminary study.

Br J Radiol 2021 May 14:20201374. Epub 2021 May 14.

Department of Medical Imaging, Subei People's Hospital, Medical School of Yangzhou University, Yangzhou, China.

Objective: To explore the feasibility of diffusion kurtosis imaging (DKI) in differentiating different types of renal cell carcinoma (RCC).

Methods: 36 patients with clear cell RCC (CCRCC, low-grade, = 20 and high-grade, = 16), 19 with papillary RCC, 11 with chromophobe RCC, and 9 with collecting duct carcinoma (CDC) were examined with DKI technique. b values of 0, 500 and 1000 s/mm were adopted. Read More

View Article and Full-Text PDF

Identification of potential genes in upper tract urothelial carcinoma using next-generation sequencing with bioinformatics and in vitro analyses.

PeerJ 2021 27;9:e11343. Epub 2021 Apr 27.

Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Background: We aimed to identify prognostic biomarkers of upper tract urothelial carcinomas (UTUCs), including microRNAs (miRNAs) and genes which account for only 5% to 10% of all urothelial carcinomas (UCs). In Taiwan, this figure is markedly higher, where it can reach up to 30% of UC cases.

Materials And Methods: Using next-generation sequencing (NGS), we analyzed two pairs of renal pelvis tumors and adjacent normal urothelial tissues to screen miRNAs and messenger RNAs. Read More

View Article and Full-Text PDF

Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma.

Sci Rep 2021 May 13;11(1):10200. Epub 2021 May 13.

Departments of Urology, Tulane University School of Medicine, 1430 Tulane Ave, New Orleans, LA, 70112, USA.

Renal Cell Carcinoma (RCC) is the most common form of kidney cancer, with clear cell RCC (ccRCC) representing about 85% of all RCC tumors. There are limited curable treatments available for metastatic ccRCC because this disease is unresponsive to conventional targeted systemic pharmacotherapy. Exosomes (Exo) are small extracellular vesicles (EVs) secreted from cancer cells with marked roles in tumoral signaling and pharmacological resistance. Read More

View Article and Full-Text PDF

Effect of radiomics from different virtual monochromatic images in dual-energy spectral CT on the WHO/ISUP classification of clear cell renal cell carcinoma.

Clin Radiol 2021 May 10. Epub 2021 May 10.

Department of Medical Image, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Electronic address:

Aim: To investigate the effect of radiomics obtained from different virtual monochromatic images (VMIs) in dual-energy spectral computed tomography (CT) on the World Health Organization/International Association for Urological Pathology (WHO/ISUP) classification of clear cell renal cell carcinoma (ccRCC).

Materials And Methods: A retrospective study of 99 ccRCC patients who underwent contrast-enhanced dual-energy CT was undertaken. ccRCC was confirmed at surgery or biopsy and graded according to the WHO/ISUP pathological grading criteria as low grade (n=68, grade I and II) or high grade (n=31, grade III and IV). Read More

View Article and Full-Text PDF

METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression.

J Transl Med 2021 May 13;19(1):209. Epub 2021 May 13.

Department of Urology, First Hospital of China Medical University, School of China Medical University, No. 155 Nanjing North Street, Heping District, Shenyang City, 110004, Liaoning Province, People's Republic of China.

Background: Clear cell renal cell carcinoma (ccRCC) is the most common and aggressive type of renal malignancy. Methyltransferase like 13 (METTL13) functions as an oncogene in most of human cancers, but its function and mechanism in ccRCC remains unreported.

Methods: qRT-PCR, western blotting and immunohistochemistry were used to detect METTL13's expression in tissues. Read More

View Article and Full-Text PDF

Renal Cell Carcinoma With Urinary Bladder Metastasis: A Case Report With Metachronous Genomic Analyses.

JCO Precis Oncol 2021 Mar 26;5. Epub 2021 Mar 26.

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.

View Article and Full-Text PDF

Case Report: Bilateral Renal Cell Carcinoma With Different Histological and Morphological Features, Clear Cell and Cystic Thyroid-Like Follicular Subtype.

Front Oncol 2021 26;11:659706. Epub 2021 Apr 26.

Department of Pathology, The First Hospital of Jilin University, Changchun, China.

Thyroid-like follicular renal cell carcinoma is a rare subtype of renal cell carcinoma that has only been recently recognized, as most cases involve a solid tumor in one kidney. In this study, we report a rare case of bilateral renal cell carcinoma wherein the tumor in the left kidney was diagnosed as clear cell carcinoma, while the tumor in right kidney as thyroid-like follicular renal cell carcinoma. The difference between this case and the ones described in previous reports is that thyroid-like follicular renal cell carcinoma showed cystic changes on imaging. Read More

View Article and Full-Text PDF